Clinical Outcomes for Metastatic Renal Cell Carcinoma (mRCC) Patients Ineligible for Front-line Clinical Trials. jkcvhl [Internet]. 2024 Aug. 30 [cited 2026 May 18];11(3):51-8. Available from: https://mail.jkcvhl.com/index.php/jkcvhl/article/view/352